Virgin Islands (U.S.)

Reimbursed Care Access

In the U.S. Virgin Islands (USVI) federal controlled-substance scheduling and local territorial law largely mirror U.S. federal prohibitions: classic psychedelics (psilocybin, DMT, 5‑MeO‑DMT, MDMA, mescaline, ibogaine, many phenethylamines like 2C‑X) are listed as controlled/hallucinogenic substances under USVI statute and are therefore unavailable outside authorized research. The only commercially approved psychedelic-derived pharmaceutical with an established regulatory/dispensing framework in U.S. jurisdictions is esketamine (SPRAVATO) — available under FDA approval and REMS requirements — while ketamine (racemic) is used off‑label in private clinics (rarely reimbursed).